Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Klupp

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Transplantation Proceedings|May 28, 2005
Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitisG Junge, R Neuhaus, L Schewior, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil for treatment of ongoing or chronic rejections after liver transplantationR Pfitzmann, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|May 30, 2001
Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563J M Langrehr, R Lohmann, R Raakow, et al.
Transplantation Proceedings|September 25, 2002
Sirolimus in late acute OKT3-resistant and/or steroid-resistant rejection after simultaneous pancreas and kidney transplantationA Kahl, M Oppert, A Müller, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Estimating the contribution of everolimus to immunosuppressive efficacy when combined with tacrolimus in liver transplantation: a model-based approachT Dumortier, M Looby, O Luttringer, et al.
Transplantation Proceedings|May 17, 2000
Infectious complications after orthotopic liver transplantation with different immunosuppressive induction regimensR Lohmann, J M Langrehr, J Klupp, et al.
Transplantation Proceedings|March 27, 2001
A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantationJ M Langrehr, J Klupp, R Pfitzmann, et al.
Transplantation Proceedings|September 19, 2006
Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantationN Kamar, P Glander, J Nolting, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2015
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trialA Pascher, P De Simone, J Pratschke, et al.
Transplantation Proceedings|June 24, 1998
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantationJ Klupp, W O Bechstein, J Pratschke, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Transplantation Proceedings|May 28, 2005
Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitisG Junge, R Neuhaus, L Schewior, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil for treatment of ongoing or chronic rejections after liver transplantationR Pfitzmann, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|May 30, 2001
Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563J M Langrehr, R Lohmann, R Raakow, et al.
Transplantation Proceedings|September 25, 2002
Sirolimus in late acute OKT3-resistant and/or steroid-resistant rejection after simultaneous pancreas and kidney transplantationA Kahl, M Oppert, A Müller, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Estimating the contribution of everolimus to immunosuppressive efficacy when combined with tacrolimus in liver transplantation: a model-based approachT Dumortier, M Looby, O Luttringer, et al.
Transplantation Proceedings|May 17, 2000
Infectious complications after orthotopic liver transplantation with different immunosuppressive induction regimensR Lohmann, J M Langrehr, J Klupp, et al.
Transplantation Proceedings|March 27, 2001
A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantationJ M Langrehr, J Klupp, R Pfitzmann, et al.
Transplantation Proceedings|September 19, 2006
Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantationN Kamar, P Glander, J Nolting, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2015
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trialA Pascher, P De Simone, J Pratschke, et al.
Transplantation Proceedings|June 24, 1998
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantationJ Klupp, W O Bechstein, J Pratschke, et al.
Pageof 6